CNPAX
Price
$73.30
Change
+$0.37 (+0.51%)
Updated
Dec 3 closing price
Net Assets
162.64B
GLVCX
Price
$77.85
Change
+$0.26 (+0.34%)
Updated
Dec 3 closing price
Net Assets
593.79M
Interact to see
Advertisement

CNPAX vs GLVCX

Header iconCNPAX vs GLVCX Comparison
Open Charts CNPAX vs GLVCXBanner chart's image
American Funds New Perspective 529A
Price$73.30
Change+$0.37 (+0.51%)
VolumeN/A
Net Assets162.64B
Invesco Global Focus C
Price$77.85
Change+$0.26 (+0.34%)
VolumeN/A
Net Assets593.79M
CNPAX vs GLVCX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. GLVCX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and GLVCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. GLVCX (594M). CNPAX pays higher dividends than GLVCX: CNPAX (0.46) vs GLVCX (0.00). CNPAX was incepted earlier than GLVCX: CNPAX (24 years) vs GLVCX (18 years). GLVCX (1.98) is less costly to investors than CNPAX (0.77). CNPAX is a more actively managed with annual turnover of: 24.00 vs. GLVCX (13.00). CNPAX has a lower initial minimum investment than GLVCX: CNPAX (250) vs GLVCX (1000). CNPAX (11.91) and GLVCX (11.41) have marching annual gain over last year. CNPAX return over 5 years is better than : 25.34 vs. GLVCX (10.24).
CNPAXGLVCXCNPAX / GLVCX
Total Expense Ratio0.771.9839%
Annual Report Gross Expense Ratio0.771.9839%
Fund Existence24 years18 years-
Gain YTD20.10514.519138%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets163B594M27,441%
Annual Yield % from dividends0.460.00-
Returns for 1 year11.9111.41104%
Returns for 3 years46.1075.5061%
Returns for 5 years25.3410.24247%
Returns for 10 years101.9992.08111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM11.120.63
+6.01%
Contineum Therapeutics
LOB33.281.11
+3.45%
Live Oak Bancshares
ALSN90.521.20
+1.34%
Allison Transmission Holdings
ATMVU7.75N/A
N/A
AlphaVest Acquisition Corp
CTSO0.73-0.04
-4.67%
Cytosorbents Corp